Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Cancer & Metabolism|November 20, 2024
Glutaminolysis is associated with mitochondrial pathway activation and can be therapeutically targeted in glioblastomaKenji Miki, Mikako Yagi, Ryusuke Hatae, et al.
The Journal of Biological Chemistry|March 20, 2014
Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastomaYu Qin, Maoyong Fu, Masamichi Takahashi, et al.
Pathology, Research and Practice|October 2, 2024
All-in-one bimodal DNA and RNA next-generation sequencing panel for integrative diagnosis of gliomaNayuta Higa, Toshiaki Akahane, Mari Kirishima, et al.
Scientific Reports|June 25, 2026
Rural medical disparities in multimodal glioblastoma treatmentYasutomo Momii, Nobuhiro Hata, Hirotaka Fudaba, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2010
The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradationIgor Vivanco, Daniel Rohle, Matthias Versele, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240Tim R Fenton, David Nathanson, Claudio Ponte de Albuquerque, et al.
Science Signaling|December 17, 2009
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapyDeliang Guo, Robert M Prins, Julie Dang, et al.
Cancer Discovery|November 8, 2011
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathwayDeliang Guo, Felicia Reinitz, Mary Youssef, et al.
Neuro-Oncology|November 4, 2024
Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up studyHirokazu Takami, Masao Matsutani, Tomonari Suzuki, et al.
Neuro-Oncology|August 21, 2020
So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?Masayuki Kanamori, Hirokazu Takami, Shigeru Yamaguchi, et al.
Pageof 11